ArticlePDF Available

Spectrophotometric estimation of linagliptin using ion-pair complexation and oxidative coupling reactions -A green approach

Authors:

Abstract and Figures

Background: Two specific spectrophotometric methods (visible region) have been established using water as a solvent and validated for the analysis of linagliptin in API and pharmaceutical dosage forms. Materials and Methods: Method-A is established on the computation of the absorbance of green-colored chromogen complex at 660 nm, which is formed by the oxidative coupling reaction of linagliptin with 3-methyl-2-benzothiazoline hydrazine in the presence of ferric chloride. Method-B is established on the computation of the absorbance of an orange-colored ion-pair chromogen at 490 nm, which is formed by the charge transfer reaction of the primary amino group of linagliptin with picric acid. Results: Beer's law is obeyed in the drug concentration range of 2-12 µg/mL and 1-25 µg/mL for methods A and B, respectively, with a correlation coefficient of 0.999. The contemplated methods are validated statistically according to ICH Q2(R1) guidelines and results are found to be within the acceptable limits. The labeled amount of linagliptin in a marketed formulation (TRAJENTA ®) is determined without interference owed to excipients. Conclusion: The contemplated green approached spectrophotometric methods can prolifically be employed for analysis of linagliptin because of its easy access in most quality control laboratories.
Content may be subject to copyright.
245 TJPS 2020, 44 (4): 245-250
http://www.tjps.pharm.chula.ac.th
Spectrophotometric estimation of
linagliptin using ion-pair complexation
and oxidative coupling reactions – A
green approach
Sunitha Gurrala, Panikumar Durga Anumolu, Sahitya Menkana,
Nikitha Gandla, Keerthi Toddi
Department of Pharmaceutical Analysis, Gokaraju Rangaraju College of Pharmacy,
Osmania University, Hyderabad, Telangana, India
ABSTRACT
Background: Two specific spectrophotometric methods (visible region) have been established
using water as a solvent and validated for the analysis of linagliptin in API and pharmaceutical
dosage forms. Materials and Methods: Method-A is established on the computation of the
absorbance of green-colored chromogen complex at 660 nm, which is formed by the oxidative
coupling reaction of linagliptin with 3-methyl-2-benzothiazoline hydrazine in the presence of
ferric chloride. Method-B is established on the computation of the absorbance of an orange-
colored ion-pair chromogen at 490 nm, which is formed by the charge transfer reaction of the
primary amino group of linagliptin with picric acid. Results: Beer’s law is obeyed in the drug
concentration range of 2–12 µg/mL and 1–25 µg/mL for methods A and B, respectively, with a
correlation coefficient of 0.999. The contemplated methods are validated statistically according
to ICH Q2(R1) guidelines and results are found to be within the acceptable limits. The labeled
amount of linagliptin in a marketed formulation (TRAJENTA®) is determined without interference
owed to excipients. Conclusion: The contemplated green approached spectrophotometric
methods can prolifically be employed for analysis of linagliptin because of its easy access in most
quality control laboratories.
Keywords: Linagliptin, spectrophotometric, 3-methyl-2-benzothiazoline hydrazine, picric acid
INTRODUCTION
Linagliptin is a competitive and reversible dipeptidyl
peptidase (DPP)-4 inhibitor that slows the breakdown
of insulinotropic hormone glucagon-like peptide
(GLP)-1 for better glycemic control in diabetes patients.
Chemically, it is known as 8-[(3R)-3-aminopiperidin-1-yl]-
7-(but-2-yn-1-yl)-3-methyl-1[(4-methylquinazolin -2-yl)
methyl]-3,7-dihydro-1H-purine-2,6-dione.
All-embracing literature survey revealed that few
analytical methods such as spectrophotometric,[1-7]
spectrofluorimetric,[8] and high-performance liquid
chromatography[9,10] were reported for the determination
of linagliptin. One colorimetric method using NQS
and vanillin as chromogenic reagents was reported.[11]
Colorimetry is found to be more sensitive and specific than
spectrophotometry (UV region). The advantage of using
chromogenic reagent in drug analysis is its selective
chemical reaction with an analyte to form a colored
derivative.[12-16] Visible spectrophotometric methods are
relatively inexpensive, simple, and faster (in terms of
sample preparation) than chromatographic techniques and
can prolifically be adopted for drug analysis due to easy
access in most quality control laboratories.
The present investigation aims to develop economic,
sensitive, and extraction-free visible spectrophotometric
methods for the estimation of the linagliptin subjugating
chemical derivatization technique. Two chromogenic reagents
(3-methyl-2-benzothiazoline hydrazine [MBTH] and picric
acid) are employed for chemical derivatization of linagliptin,
which were not reported earlier. The proposed methods
have high sensitivity and rely on the use of distilled water
as a solvent (eco-friendly) which dwindles the cost of the
experiment.
Corresponding Author:
Sunitha Gurrala,
Department of Pharmaceutical
Analysis, Gokaraju Rangaraju
College of Pharmacy, Osmania
University, Hyderabad,
Telangana, India. E-mail:
g.sunitha88@gmail.com
Received: Mar 08, 2020
Accepted: Jul 10, 2020
Published: Sep 30, 2020
Thai Journal of Pharmaceutical Sciences
Original Article
Gurrala, et al.: Colorimetric estimation of linagliptin
http://www.tjps.pharm.chula.ac.th246 TJPS 2020, 44 (4): 245-250
MATERIALS AND METHODS
Instrumentation and Chemicals
Double beam 1800 UV-Visible spectrophotometer (Shimadzu,
Japan), analytical balance (Shimadzu AUX 220, Japan), and
ultrasonic cleaner (Sonica) were used for the study. Linagliptin
standard gift sample was provided by Dr. Reddy’s Laboratories
Pvt. Ltd., Hyderabad, India. Methanol was purchased from
Qualigens, Mumbai. Ferric chloride, sodium hydroxide, and
chromogenic reagents (MBTH and picric) were purchased from
SD Fine-Chem Ltd., Mumbai. Double distilled water was used
throughout the study. Marketed dosage form (TRADJENTA®)
of linagliptin was procured from the local pharmacy.
Preparation of Solutions
The standard stock solution (1000 µg/mL) of linagliptin
was prepared by solubilizing accurately weighed 10 mg of
linagliptin in 10 mL of methanol. The solution was further
diluted with distilled water to get the required concentration
of linagliptin. Solutions of ferric chloride (3% w/v), MBTH
reagent (0.9% w/v), picric acid (0.4% w/v), and sodium
hydroxide (2M) were prepared in distilled water.
General Analytical Procedures
Method-A
Determination of linagliptin based on measurement of
oxidative-coupling derivative. Linagliptin standard solution
(100 µg/mL) of 1 mL was transferred into a volumetric
flask of 10 mL capacity. To this 2 mL of MBTH (0.9% w/v)
reagent, 2 mL of ferric chloride (3% w/v) was added, shaken
vigorously and kept aside for 10 min for color development.
The volume was contrived up to the mark with distilled water
and absorbance of green colored chromogen was measured at
660 nm against corresponding reagent blank.
Method-B
Determination of linagliptin based on the measurement of
ion-pair complex. Linagliptin standard solution (100 µg/
mL) of 1 mL was transferred into a volumetric flask of 10 mL
capacity. To this 2 mL of picric acid (0.4% w/v) reagent, 2 mL
of sodium hydroxide (2 M) was added, shaken vigorously and
kept aside for 20 min for color development. The volume was
contrived up to the mark with distilled water and absorbance
of orange-colored chromogen was measured at 490 nm against
corresponding reagent blank.
Evidence of Chemical Derivatization
The thin-layer chromatography (TLC) technique was used
with ethyl acetate:acetonitrile (8:2) as a mobile phase on pre-
coated TLC plates. Plates were spotted separately for method-A
and B with a freshly prepared solution of linagliptin, reagent
blank solution, and chromogen produced by that method.
Plates were developed in saturated chromatographic tanks
and spots were visualized in the UV chamber at 254 nm.
Validation of Methods
The proposed methods were validated for linearity, accuracy,
precision, LOD, and LOQ as per the ICH guidelines.[17]
Linearity studies
Method-A
Aliquots of standard drug solution of linagliptin (100 µg/mL)
ranging from 0.2 to 1 mL were taken into a series of 10 mL
volumetric flasks. To these flasks, 2 mL of MBTH (0.9% w/v)
reagent, 2 mL of ferric chloride (3% w/v) were added, shaken
vigorously and kept aside for 10 min for color development.
The volume was contrived up to the mark with distilled water
to get a series of standard solutions containing 2, 4, 6, 8, 10,
and 12 µg/mL of linagliptin. The absorbance of the green-
colored chromogen was measured at 660 nm against the
corresponding reagent blank.
Method-B: Aliquots of standard drug solution of linagliptin
(100 µg/mL) ranging from 0.1 to 2.5 mL were taken into a
series of 10 mL volumetric flasks. To these flasks, 2 mL of picric
acid (0.4% w/v) and 2 mL of sodium hydroxide (2 M) were
added, shaken vigorously and kept aside for 20 min for color
development. The volume was contrived up to the mark with
distilled water to get a series of standard solutions containing
1, 5, 10, 15, 20, and 25 µg/mL of linagliptin. The absorbance
of the orange-colored chromogen was measured at 490 nm
against the corresponding reagent blank.
Precision
The intra-day and inter-day precision of the proposed
colorimetric methods were established with three different
concentrations of linagliptin within the linearity range. These
solutions were prepared in triplicate on the same day and 3
consecutive days over a period of 1 week. The percent relative
standard deviation (% RSD) values were calculated.
Accuracy
The accuracy of the methods was determined by calculating
recoveries of linagliptin by the standard addition method.
Standard solutions of linagliptin were added at 80, 100,
and 120% levels to the pre-quantified sample of linagliptin
and analyzed through proposed methods. Each sample was
prepared in triplicate at each level. The amount of linagliptin
was estimated by applying obtained values to the regression
equation.
Limit of detection (LOD) and limit of quantification (LOQ)
The sensitivity of the proposed methods was determined
concerning LOD and LOQ. These were separately determined
based on standard calibration curve using 3.3 σ/s and 10 σ/s,
formulae, respectively, where s is the slope of the calibration
curve and σ is the standard deviation of the y-intercept of the
regression equation.
Assay of Linagliptin Marketed Dosage
Forms
Twenty tablets of linagliptin (TRADJENTA®) were weighed
and powdered. The powder quantity equivalent to 10 mg of
linagliptin was dissolved in 10 mL methanol and filtered using
Whatman’s filter paper. Filtrate (0.1 mL) was transferred into
a 10 mL volumetric flask, 2 mL of MBTH and 2 mL of FeCl3
(method-A)/2 mL of picric acid and 2 mL of NaOH (method-B)
were added, shaken vigorously and kept aside for 10 min/20 min.
The volume was made up to the mark with water. The absorbance
Gurrala, et al.: Colorimetric estimation of linagliptin
247 TJPS 2020, 44 (4): 245-250
http://www.tjps.pharm.chula.ac.th
of the colored chromogen was measured at 660/490 nm against
the corresponding reagent blank. The amount of linagliptin was
computed from the Beer–Lambert’s plot.
RESULTS AND DISCUSSION
Basis of Chemical Derivatization
In method-A, linagliptin undergoes an oxidative coupling
reaction with MBTH giving green colored chromogen as a
product in the presence of oxidizing agent (ferric chloride).
Oxidation (loss of two electrons and one proton) of MBTH
by ferric chloride produces an electrophilic intermediate,
which coupled at the most nucleophilic site of linagliptin and
forms a green colored chromogen [Figure 1], which absorbs
visible light maximally at a wavelength of 660 nm in a
spectrophotometer.
Method-B involves recceing the charge transfer reaction
of linagliptin with picric acid. The hydroxy group of picric acid
(Lewis acid) transfers a proton to the amine group of linagliptin
(Lewis base) leads to the formation of an ion-pair complex.
This proton transfer reaction between linagliptin and picric
acid produces orange-colored complex [Figure 2] exhibiting
absorption maxima at 490 nm in a spectrophotometer.
Evidence of Chemical Derivatization
Evidence of linagliptin chemical derivatization with proposed
reagents was ascertained by the TLC analysis of reaction
mixture. Three spots were observed with different Rf values on
both plates (method-A and method-B), indicate the presence
of three different compounds. Higher retardation factor values
were observed for derivatives [Table 1], denote the formation
of a new compound by the proposed reaction mechanism.
Optimization of Reaction Conditions
Optimization of reagent concentration, diluting solvent and
time for color development were established to accomplish
maximum absorbance and stability. The influence of variables
on absorption values of colored species was studied by varying
one parameter at a time and keeping others at constant.
Effect of reagent concentration
The effect of MBTH and picric acid concentration on their
reaction with linagliptin was studied by adding 2 mL of
various concentrations of MBTH (0.1, 0.3, 0.6, 0.9, 1.2, and
1.5 %w/v) in method-A/picric acid (0.1, 0.2, 0.3, 0.4, 0.5, and
0.6 %w/v) in method-B to a fixed concentration of linagliptin
(10 µg/mL). It was observed that absorbance values were
increased with increasing reagent concentration up to a
certain level, thereafter decreased absorbance may due to the
saturated level of reagent. In method-A, 0.9% MBTH and in
method-B, 0.4% picric acid was optimized, these levels were
adequate for reproducible and maximum color development.
Table 1: TLC analysis of linagliptin and reaction products
Sample Method-A Method-B
Rf value Rf value
Linagliptin standard 0.05±0.002 0.06±0.003
Reagent blank 0.42±0.01 0.53±0.02
Linagliptin-chemical derivative 0.68±0.03 0.77±0.02
TLC: Thin-layer chromatography
Figure 1: Oxidative coupling reaction between linagliptin and 3-methyl-2-benzothiazoline hydrazine
Gurrala, et al.: Colorimetric estimation of linagliptin
http://www.tjps.pharm.chula.ac.th248 TJPS 2020, 44 (4): 245-250
Effect of solvents
Diluting solvent plays an important role in the stability of
the colored complex. The effect of different diluting solvents
such as acetone, acetonitrile, ethanol, methanol, and distilled
water have been studied [Figure 3] for measurement under
optimized time and reagent concentration. The best sensitivity,
maximum UV absorption, and product stability were attained
when water was used as a solvent for both the methods. Both
reagents were freely soluble in water. Hence, distilled water
was selected as a diluting solvent for proposed methods that
dwindle the cost of experiment and considered as a green
approach for spectrophotometric method development.
Effect of oxidizing agent/alkalinity
In method-A, ferric chloride was utilized as an oxidizing agent for
coupling reaction between linagliptin and MBTH reagent. It was
found that reagent and an oxidizing agent (3% of ferric chloride)
at a 1:1 ratio were adequate for the formation of an electrophilic
intermediate. In method-B, sodium hydroxide was employed as
an alkaline media for ion-pair complexation between linagliptin
and picric acid. The rate of reaction increases with an increase
in sodium hydroxide concentration (first-order rate kinetic
reaction). There was also a decrease in absorbance with an
increase in hydroxide concentration (more than 2 M) due to a
backward reaction. Hence, 2M sodium hydroxide was optimized
and 1:1 ratio of picric acid:sodium hydroxide was adequate for
the formation of orange-colored chromogen with linagliptin.
Optimization of reaction time
The optimum reaction time was determined by monitoring
the color development at different time intervals. Maximum
absorbance values were obtained at 10 min for method-A
and 20 min for method-B. The color developed for linagliptin
derivatives was stable up to 6 h with both reagents under
optimized conditions.
Stoichiometry of reaction
Stoichiometry of reaction in method-A and method-B was
studied by continuous variation method. Equimolar solutions
(2.11 × 10−5 M) of linagliptin and reagents (MBTH and picric
acid) were prepared in distilled water. The drug and reagent
(MBTH- method A/Picric acid-method B) were mixed in various
proportions to produce different mole ratio values (0, 0.2, 0.4,
0.5, 0.6, 0.8, and 1). The stoichiometric relationship exhibited
in Figure 4. A mole ratio of 0.5 gave the highest absorbance
value for both methods. This indicates that linagliptin has
one center (primary amino group) available for chromogenic
reaction with reagents at their optimum wavelengths.
Validation of Proposed Methods
The proposed methods were statistically validated as per the
ICH guidelines and results are depicted in Table 2. Linear
regression analysis was performed for the Beer’s Law data and
Figure 3: Effect of solvent on linagliptin reaction with 3-methyl-2-
benzothiazoline hydrazine and picric acid
Figure 2: Ion-pair complexation between linagliptin and picric acid
Gurrala, et al.: Colorimetric estimation of linagliptin
249 TJPS 2020, 44 (4): 245-250
http://www.tjps.pharm.chula.ac.th
Table 3: Results of precision studies using proposed methods
Method Concentration
linagliptin (µg/mL)
Intra-day analysis Inter-day analysis
Amount found
(AM ±SD),
n
=3
% RSD Amount found
(AM ±SD),
n
=3
% RSD
Method-A 4 3.96±0.011 0.27 4.01±0.012 0.299
6 6.1±0.023 0.377 5.96±0.021 0.352
8 8.1±0.023 0.283 8.27±0.025 0.302
Method-B 5 5.06±0.004 0.079 5.2±0.002 0.038
10 9.92±0.021 0.211 10.2±0.01 0.09
15 14.9±0.019 0.127 14.8±0.02 0.135
calibration plots were drawn (correlation coefficient 0.999). A
linear increase in the absorbance was found with an increase in
linagliptin concentration at a range of 2–12 and 1–25 µg/ml of
linagliptin by methods A and B, respectively. Overlaid UV-Visible
spectra of linagliptin in the linearity range are shown in
Figures 5 and 6. The reproducibility of proposed methods was
evinced by precision studies [Table 3], where no significant
difference between intra- and inter-day precision values was
observed and % RSD values were less than 2. The results of
accuracy studies are demonstrated in Table 4. The % recoveries
of linagliptin denote the fair accuracy of proposed methods
with no interference of tablet excipients. A high value of molar
absorptivity and low values of Sandell’s sensitivity, LOD, and
LOQ signposts the good sensitivity of proposed methods.
Assay of Linagliptin Marketed Dosage
Forms
The proposed methods were applied for the assay of marketed
dosage forms containing linagliptin (label claim 5 mg). The %
assay of linagliptin found to be 99.8 and 100.3 by method-A
Table 2: Optimized characteristics of linagliptin
Parameters Value
MBTH Picric acid
Absorption
wavelength (nm)
660 490
Beers law range
(µg/mL)
2–12 1–25
Regression
equation (y)
Y=0.102x+0.011 Y=0.036x–0.002
Correlation
coefficient(r2)
0.999 0.999
Limit of Detection
(µg/ml)
0.35 0.091
Limit of
Quantification (µg/ml)
1.17 0.27
Molar Absorptivity
(L mole−1cm−1)
0.393×1050.189×105
Sandell’s sensitivity
(µg cm−2)
1.2×10−2 2.5×10−2
Stability of colored
species
6 h 7 h
MBTH: 3-methyl-2-benzothiazoline hydrazine
Figure 4: Job’s continuous variation plot for method-A and method-B
Figure 6: Overlaid UV-Visible spectra of linagliptin (1–15 µg/mL)
with picric acid
Figure 5: Overlaid UV-Visible spectra of linagliptin (2–12 µg/mL)
with 3-methyl-2-benzothiazoline hydrazine
Gurrala, et al.: Colorimetric estimation of linagliptin
http://www.tjps.pharm.chula.ac.th250 TJPS 2020, 44 (4): 245-250
and method-B, respectively. There was no interference of
formulation excipients during the estimation of linagliptin in
tablets. The assay values were found to be within the limits
and % RSD was <2.
CONCLUSION
In this study, two spectrophotometric methods were developed
which evaded the use of organic solvents for analysis of
linagliptin in bulk and pharmaceutical dosage form. Chemical
derivatization mechanisms for linagliptin with MBTH and
picric acid were proposed. Proposed methods were passes
through validation parameters as per the ICH guidelines. The
assay values were in good agreement with the label claim and
suggested that no interference of formulation excipients during
the estimation of the drug. Contemplated methods are more
sensitive, less chemical perilous, and versatile over reported
methods. These have broad linearity range, high precision, and
accuracy. Hence, the proposed eco-friendly and economical
methods can be routinely employed in the quality control for
analysis of linagliptin in the pharmaceutical dosage forms.
ACKNOWLEDGMENTS
The authors express their gratitude the management of
Gokaraju Rangaraju College of Pharmacy for providing
research equipment and facilities.
REFERENCES
1. Sangeetha, RK, Subashri T. Analysis of linagliptin in tablet dosage
form by UV spectroscopy method, its derivatives and difference
spectra. Eur J Pharm Med Res 2016;3:536-40.
2. Saroj G, Smita, AS, Ravindra SB. Spectrophotometric and
chromatographic estimation of linagliptin in bulk and tablet
dosage form. Int J Chemtech Res 2017;10:736-44.
3. Anusha A, Sudhakar M. UV-spectrophotometric method for the
estimation of linagliptin in bulk and pharmaceutical formulations.
Asian J Res Chem 2016;9:47-50.
4. Sujan B, Mohammad SH. Development and validation of a
simple and rapid UV spectrophotometer method for the assay of
linagliptin in bulk and marketed dosage form. Indian J Nov Drug
Deliv 2013;5:221-4.
5. Sujan B, Palash K, Anowar HM. Development and validation of a
UV-spectrophotometric method for determination of vildagliptin
and linagliptin in bulk and pharmaceutical dosage forms.
Table 4: Results of accuracy studies of proposed methods with tablets
Method Level of
recovery (%)
Conc. test
sample (µg/mL)
Conc. standard
spiked (µg/mL)
Total amount
(µg/mL)
Amount recovery
(AM±SD), n=3
(µg/mL)
%
recovery
% RSD
Method-A 80 4 3.2 7.2 7.15±0.06 99.8 0.83
100 4 4 8 7.92±0.04 99.9 0.505
120 4 4.8 8.8 8.75±0.03 99.4 0.342
Method-B 80 10 8 18 17.99±0.08 99.44 0.446
100 10 10 20 19.92±0.06 99.5 0.030
120 10 12 22 21.9±0.05 99.81 0.227
RSD: Relative standard deviation
Bangladesh Pharm J 2015;18:163-8.
6. Lilian S. Development of economic UV spectrophotometric
method for determination of linagliptin in its ternary mixture
with empagliflozin and metformin: Comparison to economic
pharmaceutical analysis in literature. Pharm Lett 2016;8:267-9.
7. Ayoub BM, EI-Bagary RI, Elkadly EF. Spectrophotometric
methods for the determination of linagliptin in binary mixture
with metformin hydrochloride and simultaneous determination
of linagliptin and metformin hydrochloride using RP-HPLC. Int J
Biomed Sci 2013;9:41-7.
8. Ayoub BM, EI-Bagary RI, Elkady EF. Spectrofluorimetric
determination of linagliptin in bulk and pharmaceutical dosage
form. Eur J Chem 2014;5:380-2.
9. Prathyusha V, Dilip D, Umamahesh B, Shyam P, Veeresham C.
Simultaneous determination of linagliptin and metformin by
reverse phase-high performance liquid chromatography method:
An application in quantitative analysis of pharmaceutical dosage
forms. J Adv Pharm Technol Res 2015;6:25-8.
10. Sharmila D, Achanta S. Validated HPLC-UV method for
simultaneous estimation of linagliptin and empagliflozin in
human plasma. Int J Appl Pharm 2018;10:56-61.
11. Panikumar AD, Sowndarya NS, Rajeshwari G, Radhagayathri A,
Sunitha G. Quantification of linagliptin by chemical derivatization
with appliance of chromogenic reagents. J Appl Chem Res
2016;11:39-50.
12. Panikumar AD, Archana G, Sunitha G. Simplistic application
of MBTH, an oxidative coupling chromogenic reagent for
quantification of metaxalone and dabigatran etexilate mesylate
bulk drug and their dosage forms. Pharm Anal Acta 2015;6:362.
13. Varsha SM, Raghavendra BN, Padmavathi Y. Development of new
spectrophotometric method for estimation of tenofovir disoproxil
fumarate using MBTH reagent. Int Curr Pharm J 2015;4:378-81.
14. Kumar AV, Reddy TV, Sekharan CB. Utility of picric acid
and 2, 4 dinitrophenol as chromogenic reagents for visible
spectrophotometric quantification of alogliptin. Bull Fac Pharm
Cairo Univ 2017;55:177-18.
15. Shaik IN, Narayana B. Spectrophotometric determination and
spectroscopic studies on Schiff base and charge transfer complex
of ketorolac tromethamine. J Anal Sci Technol 2015;6:32.
16. Olajire AA, Babalola PC, Olayinka AK, Obuebhor O. Simultaneous
spectrophotometric determination of trimethoprim and
sulphamethoxazole following charge-transfer complexation with
chloranilic acid. Arab J Chem 2017;10:S3848-60.
17. International Conference on Harmonization (ICH) of Technical
Requirements for Registration of Pharmaceuticals for Human
Use, Validation of Analytical Procedures: Text Methodology,
Q2 (R1). Geneva: International Conference on Harmonization;
2005. p. 6-13.
... The developed methods were based on the implementation of simple oxidation reactions of both LNG and EMG without interaction with other ingredients in their drug formulations [20,21]. The proposed methods are selective, eco-friendly, and cost-effective since they use non-toxic inorganic reagents, and no organic solvents and reagents were used. ...
... The proposed processes underwent validation using reference methodologies. These techniques were compared to those for LNG [20] and EMG [21] in dose formulations that had been published. The statistical findings demonstrate good precision and accuracy in the assay of the pharmaceuticals under study using the suggested and cited techniques (Table 3). ...
Article
Full-text available
The frequent drugs prescribed for type 2 diabetes patients are linagliptin (LNG) and empagliflozin (EMG) in different drug formulations. The objective of this research is to create and validate selective and simple methods to evaluate both medications in their dosage forms. Method A for the assay of LNG is based on the drug oxidation using an iodate/iodide mixture, while Method B involves the determination of EMG using permanganate oxidation. The regression graphs had good linearity in the ranges of 0.25–20 and 0.20–1.5 µg·ml⁻¹ for the two drugs, respectively. The limits of detection were 0.082 and 0.065 µg·ml⁻¹ for LNG and EMG, respectively. The two methods were validated and applied for the assay of the drugs in dosage forms successfully.
... All the previous articles depend on the HPLC method which requires expensive equipment and materials. On the other hand, the published articles about determining LNG in pharmaceutical forms using a VIS spectrophotometer (13,14) didn't mention a method to determine it in combination drug products alongside EMPA and MET. ...
Preprint
Full-text available
Linagliptin is an oral antidiabetic agent, used to treat type 2 diabetes. It is taken orally independently or in combination with Empagliflozin and Metformin HCl. Chromatographic Analysis methods were demonstrated for simultaneous analysis of two or three antidiabetic drugs (Linagliptin, Empagliflozin and/or Metformin). This article is interested in the validation of a simple, fast and specific method that relies on chemical derivatization and uses a VIS spectrophotometer to determine LINA in pure and combination drug products alongside Empagliflozin and Metformin. The developed method was reached by reacting LNG with Para-Dimethylaminobenzaldehyde (PDAB) 5% in an acidic medium (Hydrochloride 37%) in a water bath to produce a yellow Schiff base which can be measured at a wavelength of 407 nm. The developed method has good accuracy and precision. PDAB does not interact with Empagliflozin or Metformin under these optimal conditions. Therefore, this developed method is distinguished by its accuracy and specificity in assaying Linagliptin both alone and in combination drug products.
... The non-covalent interactions of complex formation are correlated with the development of intensity-coloured complexes that absorb visible-spectrum radiation. A comprehensive review of the available literature found that a number of analytical techniques, such as spectrophotometric [19][20][21][22][23][24][25][26][27][28][29][30], colorimetric [31][32][33], spectrofluorometric [33][34][35], and high-performance liquid chromatographic [36][37][38][39] methods, were described for the detection of linagliptin. It has been determined that colorimetric is more specific than spectrophotometry (UV region). ...
Article
Full-text available
This study describes the non-covalent interactions of the charge transfer complex (CT), which was responsible for the synthesis of Linagliptin (LNG) with 2, 3-Dichloro-5, 6-Dicyano-1, 4-benzoquinone (DDQ), or with chloranilic acid (CHA) complexes in acetonitrile (MeCN) at temperatures of (25 ± 2 °C). Then, a UV–Vis spectrophotometer was utilized to identify Linagliptin (LNG) from these complexes. For the quantitative measurement of Linagliptin in bulk form, UV–Vis techniques have been developed and validated in accordance with ICH criteria for several aspects, including selectivity, linearity, accuracy, precision, LOD, LOQ, and robustness. The optimization of the complex synthesis was based on solvent polarization; the ratio of molecules in complexes; the association constant; and Gibbs energy (ΔG°). The experimental work is supported by the computational investigation of the complexes utilizing density functional theory as well as (QTAIM); (NCI) index; and (RDG). According to the optimized conditions, Beer’s law was observed between 2.5–100 and 5–100 µM with correlation coefficients of 1.9997 and 1.9998 for LGN-DDQ and LGN-CHA complexes, respectively. For LGN-DDQ and LGN-CHA complexes, the LOD and LOQ were (1.0844 and 1.4406 μM) and (3.2861 and 4.3655 μM), respectively. The approach was successfully used to measure LGN in its bulk form with high precision and accuracy.
... Stability: It is stable if stored as directed; avoid strong oxidizing agents [2] Linagliptin isn't available as a speci c method about analyzing in British pharmacopeia (BP) or United States Pharmacopeia (USP). The Review of Research Literature has shown several articles for the determination of LNG in pharmaceutical forms, including the spectrophotometer in UV [3][4][5], also in VIS with chemical derivation using NQS (1,2-naphtho quinine 4-sulphonic acid sodium salt), vanillin[6] and picric acid [7] as a chromogenic reagents. Capillary Electrophoresis (CE) [8], and with high-performance liquid chromatography (HPLC) [9][10][11][12][13]. ...
Preprint
Full-text available
A simple, economical and specific analytical method have been developed for determining and validation Linagliptin (LNG) in bulk. This method is based on condensation reaction between a primary amine in LNG and aldehyde group in P-Dimethylaminobenzaldehyde (PDAB) to form the yellow Schiff base with a wavelength at 407 nm. The optimum experimental conditions for the formulation of the colored complex have been studied. The optimum conditions were 1 ml of 5% w/v reagent solution with methanol and distilled water as a solvent for both PDAB, LNG respectively, also adding 2 ml of HCl as an acidic medium, heating to 70 - 75℃ on a water bath for 35 minutes. Furthermore, the stoichiometry of reaction has been studied according to Job’s and Molar ratio method which was expressing 1:1 for LNG and PDAB. The researcher modified the method. The results show that the linearity in the concentration range (5-45 µg/ml) with correlation coefficient R² = 0.9989 with percent recovery (99.46 – 100.8%) and RSD was less than 2%, LOD and LOQ 1.5815 -4.7924 μg/ml respectively. This method can show a high quality and there is no significant interference with excipients and in pharmaceutical forms. None of the studies showed a developing of this method before.
... Literature data reports some analytical studies involving chromatographic [11][12][13][14][15][16][17], spectrophotometric [18,19] and spectroflourimetric [20,21] methods for EMP alone or with other antidiabetic drugs and for LIN there are some chromatographic [22][23][24][25][26][27][28][29], spectrophotometric [30,31], electrochemical methods [32,33] for LIN. ...
Article
A new and simple spectrophotometric method was developed for the simultaneous determination of a new antidiabetic mixture of linagliptin and empagliflozin namely fourier self deconvulated method. The developed method based on minimal mathematical data processing on the zero order spectrum for solving sever overlapping spectra of the mentioned drugs in their pure forms and pharmaceutical dosage form. The zero order spectra of linagliptin and empagliflozin were deconvulated using Fourier transforms function. The peak amplitudes at 232 nm were selected for linagliptin and at 239 nm for empagliflozin. The constructed calibration graphs were linear over the range (5-30 µg/mL) and (2-12 µg/mL) for empagliflozin and linagliptin, respectively. The adopted method was simple, accurate, precise and validated according to the ICH guidelines.
Article
Full-text available
A simple, rapid, accurate, precise UV spectrophotometric method was developed for simultaneous determination of empagliflozin and linagliptin without prior separation. The simultaneous determination was based on the area under the curve (AUC) correction method, where the determination was within the ranges 221-229 nm and 291-310 nm for empagliflozin and linagliptin, respectively. Linearity for empagliflozin was obtained over (2.5 – 35 µg/ml), while Linearity for linagliptin was obtained over (2.5 – 30 µg/ml) and from this range the concentrations of linagliptin between (2.5 – 10 µg/ml) were used for the simultaneous determination of empagliflozin and linagliptin within the range 221-229 nm. The method has been validated by the studying of linearity, precision, accuracy, recovery, and the quantitation limit was 1.5 µg/ml, 1.3 µg/ml for empagliflozin and linagliptin respectively, while the detection limit was 0.5 µg/ml, 0.4 µg/ml for empagliflozin and linagliptin respectively. This method can be applied on pharmaceutical products without interaction with excipients.
Article
Type 2 diabetes can be cured by using tradjenta (also known as Linagliptin), a new therapeutic drug that is an inhibitor of the dipeptidyl peptidase-4 enzyme. Tradjenta is administered orally alone or in combination with metiguanide or empagliflozin. An easy and specific fluorimetric analysis of Tradjenta was developed and demonstrated in the present investigation. The Hantzsch reaction method, which generates a fluorescent dihydropyridine derivative, is the basis of this assay. In a Toerell-Stenhagen buffered solution, the unsubstituted amine group of Tradjenta interacted with 2,4-Pentadione/Oxomethane. Spectrofluorimetry was utilized for this investigation at an excitation/emission wavelength of 421/480 nm. When comparing the Tradjenta concentration to the tracked fluorimetric signal, the method revealed linearity over the concentration range of 0.05 to 1.2 µg/mL. By strictly altering system parameters and analyzing the validation factors following International Council for Harmonisation (ICH) requirements, the outcomes were achieved. Finally, the proposed approach was successfully applied to assay the drug not only in its raw form and prescribed formulations but also to evaluate the tablet's uniformity of content.
Article
Full-text available
A simple, economical, and specific analytical method has been developed for determining and validating linagliptin (LNG) in bulk. This method is based on a condensation reaction between a primary amine in LNG and an aldehyde group in P-dimethylaminobenzaldehyde (PDAB) to form the yellow Schiff base with a wavelength of 407 nm. The optimum experimental conditions for the formulation of the colored complex have been studied. The optimum conditions were 1 mL of 5% w/v reagent solution with methanol and distilled water as a solvent for both PDAB, LNG respectively, also adding 2 mL of HCl as an acidic medium, heating to 70–75 °C on a water bath for 35 min. Furthermore, the stoichiometry of the reaction has been studied according to Job’s and Molar ratio method which was expressing 1:1 for LNG and PDAB. The researcher modified the method. The results show that the linearity in the concentration range (5–45 µg/mL) with correlation coefficient R² = 0.9989 with percent recovery (99.46–100.8%) and RSD was less than 2%, LOD and LOQ 1.5815 − 4.7924 μg/mL respectively. This method can show high quality and there is no significant interference with excipients and in pharmaceutical forms. None of the studies showed the development of this method before.
Article
Full-text available
Two simple, specific, accurate, precise, sensitive and cost effective spectrophotometric methods have been developed and validated for quantification of linagliptin in pure form and pharmaceutical formulations. Method A is established on the computation of absorbance of purple coloured chromogen complex at 463 nm which is formed by the condensation reaction of the primary amine group of linagliptin with vanillin (Schiff base formation). Method B is established on computation of absorbance of orange coloured chromogen at 454 nm which is formed by the condensation reaction of the primary amino group of linagliptin with NQS (1,2-naphtho quinine 4-sulphonic acid sodium salt) reagent. Two methods executed linearity in the concentration range of 2.5-20 µg/ml and 10-90 µg/ml for method A and B respectively. Linear relationship with good correlation coefficients of 0.998 and 0.995 were monitored between absorbance and corresponding concentrations of linagliptin in vanillin and NQS respectively. The limit of detection, limit of quantification, molar absorptivity, sandell's sensitivity and ring born concentration P. D. Anumolu et al., J. Appl. Chem. Res., 11, 2, 39-50 (2017) 40 values were determined for the two spectrophotometric methods. The contemplated methods were validated statistically as per ICH guidelines. The reliability of both the methods is further ascertained by performing recovery tests by standard addition method. No significant interference was inspected from the excipients commonly used as pharmaceutical aids with the assay procedure. The contemplated methods were simple, sensitive, specific and can be successfully employed in routine analysis of linagliptin in pharmaceutical dosage forms.
Article
Full-text available
Two simple and sensitive visible spectrophotometric methods (A and B) were developed for the determination of alogliptin in bulk and in its tablet dosage forms. The methods use the reaction of alogliptin with picric acid (method A) or 2,4 dinitrophenol (method B) in the chloroform medium. The complex of alogliptin with picric acid (method A) or 2,4 dinitrophenol (method B) showed λmax at 415 nm and 430 nm respectively. The different conditions affecting the formation and stability of the complexes were optimized. The methods were validated statistically according to ICH. The calibration curve is linear over the concentration range of 10–60 μg ml⁻¹ and 10–50 μg ml⁻¹ for methods A and B, respectively. The proposed methods were successfully applied for the assay of alogliptin in tablets with good recoveries. Interference was not observed from common tablet excipients.
Article
Full-text available
Ketorolac tromethamine is a versatile analgesic drug used extensively for the treatment of fever and moderate to severe pain. It is a potent non-steroidal anti-inflammatory drug that extends opioid-level analgesia to patients. Two new selective methods are proposed for spectrophotometric determination of ketorolac tromethamine (KT) in pure and pharmaceutical formulation. The determination procedures are based on the condensation reaction of KT with 2,4-dinitrophenylhydrazine (DNPH) in strongly alkaline medium resulting in the formation of red-colored hydrazones which is quantitated at 424 nm for method A and method B involves the charge transfer reaction between KT as electron donor and 7,7′,8,8′-tetracyanoquinodimethane (TCNQ) as π-acceptor to form dark green-colored complex which is measured at 842 nm. Linear correlation is obtained in the range 0.50–18.50 μg mL −1 and 2.00–50.00 μg mL −1 with detection limits of 0.1579 and 0.3721 μg mL −1 for method A and method B, respectively. The optimum analytical conditions are analyzed, and the proposed assay is validated as per the ICH guidelines. The developed methods are effectively applied to the determination of KT in tablets, injections, and ophthalmic formulations with good percentage recoveries. The final reaction products are characterized by spectral analysis (FT-IR and 1 H NMR). In addition, the surface morphology of the reaction products are also studied using scanning electron microscopy.
Article
Full-text available
Purpose: A simple and sensitive spectrophotometric method in visible region has been developed and validated for quantification of metaxalone (MET) and dabigatran etexilate mesylate (DAB) in their bulk and pharmaceutical dosage forms. Methods: The method is based on the oxidative coupling reaction of 3-methyl-2-benzothiazoline hydrazone (MBTH) with MET and DAB in the presence of ferric chloride to form green coloured chromogen with absorption maximum at 666 nm and 632 nm respectively. Results: Beer’s law is obeyed in concentration range of 4-20 and 1-6 μg/mL for MET and DAB respectively with correlation coefficient of 0.999. Limit of detection and quantification were 0.46 μg/mL and 1.518 μg/mL for MET and 0.0578 μg/mL and 0.298 μg/mL for DAB. When marketed formulations were analyzed, the results obtained by the proposed method were in good agreement with labelled amounts. The developed method was validated statistically as per ICH guidelines. Conclusion: The developed method is simple, sensitive, specific and can be successfully employed in routine analysis of MET and DAB pharmaceutical dosage forms.
Article
Full-text available
A new simple, sensitive and specific procedure has been developed for determination of tenofovir disoproxil fumarate in bulk and pharmaceutical dosage forms using MBTH reagent. The purpose of this analytical validation procedure is to validate it by laboratory experiments to prove that the method meets the minimum standards for laboratory use. 3-methyl-2-bezothiazoline hydrazone reacts with the secondary amine group of tenofovir in the presence of oxidizing agent, ferric chloride. The resulting apple green coloured chromogen when measured spectrophotometrically in visible region ( i.e. , 400-800nm) shows a maximum absorbance at 626.5nm. This method can be successfully applied for the determination of drug content in pharmaceutical formulations. The results of analysis have been validated statistically. DOI: http://dx.doi.org/10.3329/icpj.v4i4.22620 International Current Pharmaceutical Journal, March 2015, 4(4): 378-381
Article
Full-text available
To enhance patient compliance toward treatment in diseases like diabetes, usually a combination of drugs is prescribed. Therefore, an anti-diabetic fixed-dose combination of 2.5 mg of linagliptin 500 mg of metformin was taken for simultaneous estimation of both the drugs by reverse phase-high performance liquid chromatography (RP-HPLC) method. The present study aimed to develop a simple and sensitive RP-HPLC method for the simultaneous determination of linagliptin and metformin in pharmaceutical dosage forms. The chromatographic separation was designed and evaluated by using linagliptin and metformin working standard and sample solutions in the linearity range. Chromatographic separation was performed on a C18 column using a mobile phase of 70:30 (v/v) mixture of methanol and 0.05 M potassium dihydrogen orthophosphate (pH adjusted to 4.6 with orthophosphoric acid) delivered at a flow rate of 0.6 mL/min and UV detection at 267 nm. Linagliptin and metformin shown linearity in the range of 2-12 μg/mL and 400-2400 μg/mL respectively with correlation co-efficient of 0.9996 and 0.9989. The resultant findings analyzed for standard deviation (SD) and relative standard deviation to validate the developed method. The retention time of linagliptin and metformin was found to be 6.3 and 4.6 min and separation was complete in <10 min. The method was validated for linearity, accuracy and precision were found to be acceptable over the linearity range of the linagliptin and metformin. The method was found suitable for the routine quantitative analysis of linagliptin and metformin in pharmaceutical dosage forms.
Article
Full-text available
This work reports a simple, rapid, accurate and precise UV-spectrophotometric method for the assay of Linagliptin in bulk and marketed tablet dosage form has been developed. The method was linear in the range of 5 and 30 μg/ml presenting a good correlation coefficient (r=0.999). Method is validated as per ICH guideline and this study is statistically significant as all the statistical parameters are within the acceptance range (% RSD < 2.0 and SD < 2.0) for both accuracy and precision.
Article
Simple and precise spectrofluorometric method has been developed and validated for the determination of linagliptin (LNG) in the range of 10-110 μg/mL. The results obtained were of good precision and statistically compared to the reference method using one-way analysis of variance (ANOVA). The method developed was satisfactorily applied to the analysis of the pharmaceutical formulation and proved to be specific and accurate for the quality control of linagliptin in its pharmaceutical dosage form. The development of spectrofluorometric method for the determination of LNG was of interest as no such methods have been reported.